gvtcx

UK NEQAS Antimicrobial Susceptibility Quality Assessment (published 22 September 2020)

UK Health Security Agency Published 31 Jul 2023 Contracts Finder

key details

Statuscomplete
Category (CPV) 75122000
Deadline7 Sept 2020
Contract start22 Sept 2020
Contract end31 Aug 2025
SME suitableYes
OCIDocds-b5fd17-26d5a03f-c22a-4679-a30d-a6583def01a3

Award

SupplierValueDateStatus
MW AMR CONSULTANCY LTD £42,000 27 Sept 2020 active

description

Re-issued CAN to correct the CF Contract Award Notice for PHE - Corporate - UK NEQAS Antimicrobial.

Amended to reflect the Maximum Term and Contract Value as advertised and stated in the tender documents as the original CAN mistakenly only declared the term and value relating to the initial term not the maximum possible, including potential extensions.

The contract will be for an initial 3 year period with the options for the Contracting Authority to extend for up to two further periods of 1 year (+1+1). The maximum value of the procurement (excluding VAT): £42,000

Public Health England (PHE) now UKHSA required a supplier to provide expert commentary on bacterial resistance profile to antibiotics and the genetic mechanism they use to become resistant to these antibiotics.

Link to previous CF Contract Award Notice: https://www.contractsfinder.service.gov.uk/notice/63d3c2a0-1658-4a26-8a69-2d4e66203213?origin=SearchResults&p=1

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
31 Jul 2023 Award (award) · 01f44303-5996-442e-816c-e3b0fcf1968f-667321

more from UK Health Security Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.